ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 7/9/2026

1. USO
2. SPY
3. AMZN
4. GNK
5. FLUT
6. TMUS
7. AVGO
8. KRUS
9. MTZ
10. BKR

Go back to ATARA Biotherapeutics (ATRA) Presents Data Demonstrating Safety & Sustained Disability Improvement at 12 Months with ATA188 in Patients with Progressive MS in Late-Breaking e-Poster at EAN

ATARA Biotherapeutics (ATRA) Prices 12.63M Share Common Offering at $11.32/Sh

May 27, 2020 5:57 AM EDT

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) today announced the pricing of an underwritten public offering of 12,633,039 shares of its common stock at a price to the public of $11.32 per share and, to certain investors, pre-funded warrants to purchase 2,866,961 shares of its common stock at a purchase... More

ATARA Biotherapeutics (ATRA) Announces Proposed Common Share & Pre-Funded Warrants Offering

May 26, 2020 4:06 PM EDT

Atara Biotherapeutics, Inc. (NASDAQ: ATRA) today announced that it has commenced an underwritten public offering of shares of its common stock and, to certain investors, pre-funded warrants to purchase shares of its common stock. The pre-funded warrants will be offered at the same price per share as the common... More